Citations

Showing 10 of 108094 citations.

Allograft-Prosthetic Composite Reconstruction for Massive Proximal Humeral Bone Loss in Reverse Shoulder Arthroplasty
Sánchez‐Sotelo, Joaquín , Wagner, Eric R. , Sanchez-Sotelo, J. , Wagner, Eric R , Houdek, Matthew T.

Mayo Clinic

JBJS Essential Surgical Techniques | January 24, 2018 | Volume: 8 | Issue: 1 | Pages: e3

10.2106/jbjs.st.17.00051 | PMID 30233975 Get It

Background: Allograft-prosthetic composite (APC) reconstruction of the humerus represents an appealing surgical technique when implantation of a reverse prosthesis is considered in the setting of substantial proximal humeral bone loss 1–4 . Humeral APCs have been successfully performed in the past with a non-reverse shoulder prosthesis 4,5 . Reconstruction of the proximal part of the humerus with an allograft provides adequate support and fixation for the humeral component, allows restoration of length and lateral offset, and provides an opportunity for soft-tissue reattachment when needed. On the basis of the available peer-reviewed data, healing at the allograft-host junction is reliable, and complication rates, including instability, are relatively low 3,6 . Description: Once the glenoid reverse component has been implanted, a proximal humeral allograft is prepared to receive the humeral component of a reverse arthroplasty. The allograft is procured by our institutional bone and tissue bank, purchased from a number of vendors. The graft is selected after review of the description and radiographs provided by the vendor. The priority is to obtain a graft with sufficient length and soft tissues attached. If possible, the graft selected should have a diameter close to the diameter of the humerus of the recipient. The desired allograft length is selected on the basis of preoperative planning and intraoperative measurements, and the distal portion of the allograft is resected accordingly. Depending on the length of the defect, host bone quality, and surgeon preferences, the humeral component may or may not bypass the host-graft junction. The stem bypasses the host-graft junction for shorter APCs, as well as when the bone quality of the native humerus is compromised. Cemented fixation into the graft is universally used. Compression plating is used for graft-to-host fixation, supplemented by implantation of the stem across the junction in selected cases. Care is taken during the freehand cut to obtain optimal contact and compression. Once the ideal humeral bearing thickness has been selected, the polyethylene bearing is implanted and the joint relocated. If the posterior cuff can be repaired to cuff allograft, sutures are placed prior to relocation and are tied after relocation. Other musculotendinous units, such as the deltoid or pectoralis major, are repaired to the allograft if needed. Alternatives: Implantation of a reverse prosthesis with a proximal humeral metal body (a so-called tumor prosthesis) is the main alternative to proximal humeral APC reconstruction. In patients with shorter defects, adequate soft-tissue tension may be obtained by implanting a glenosphere with a large inferior eccentricity and cementing the humeral component in a more proximal position than is usually performed. Alternatively, when implantation of the glenoid component of a reverse prosthesis is not possible, a hemiarthroplasty-APC construct may be performed 1,4,5,7–10 , adding a synthetic sleeve such as an aortic Dacron graft to enhance soft-tissue stability if needed. Rationale: When reverse arthroplasty is performed in the setting of substantial humeral bone loss, the humeral component may be poorly supported and at risk for loosening. In addition, the absence of proximal humeral bone stock may lead to shortening and/or loss of lateral offset. Finally, the posterosuperior cuff, subscapularis, deltoid, and pectoralis tendons may remain detached. The potential consequences of humeral bone loss in the setting of reverse arthroplasty include humeral loosening, dislocation, and poor active motion (particularly poor active elevation). Allograft reconstruction of the proximal part of the humerus provides an opportunity for better support of the component, restoration of humeral length and lateral offset, and attachment sites for the musculotendinous structures around the shoulder, if needed.
Mycobacterial spindle cell pseudotumour: epidemiology and clinical outcomes
Sfeir, Maroun M. , Borczuk, Alain , Soave, Rosemary, Jenkins, Stephen G., Walsh, Thomas J. , Small, Catherine B. , Schuetz, Audrey, Schuetz, Audrey N. , Besien, Koen van

Mayo Clinic

Journal of Clinical Pathology | January 24, 2018 | Volume: 71 | Issue: 7 | Pages: 626-630

10.1136/jclinpath-2017-204777 | PMID 29367301 Get It

Introduction Mycobacterial spindle cell pseudotumour (MSP) is a rare disease characterised by tumour-like local proliferation of spindle-shaped histiocytes containing acid-fast positive mycobacteria. The aim of this literature review is to describe the clinical parameters and treatment outcomes of patients with MSP. Methods A literature search was conducted using the search terms related to mycobacteria and spindle cell tumours. A previously unreported stem cell transplant recipient from our institution diagnosed with MSP was also included. Demographics, comorbidities, site of infection, treatment and clinical outcomes were analysed. Results Fifty-one patients were analysed. Twenty-six (51%) had HIV infection. Mycobacterium avium complex was the most frequent organism isolated in 24 (47.1%) followed by Mycobacterium tuberculosis complex in eight (16%) cases. Lymph nodes were the most common site of infection (45.1%). Twenty (39.2%) patients received antimycobacterial agents, 12 (23.5%) underwent surgical resection and six (11.8%) received antimycobacterial agents plus surgery. Treatment was successful in 24 (47.1%) patients and failed in 15 (29.4%); 13 of these 15 patients died. Antimycobacterial therapy was significantly associated with successful outcome compared with surgical resection or no treatment (P<0.001). Conclusion MSP is a rare condition associated primarily with immunodeficiencies. Antimycobacterial therapy is significantly associated with successful outcome.
Intraoperative evaluation of limb length in hip arthroplasty using a single AP radiograph
DeOrio, James K.

Mayo Clinic

HIP International | January 24, 2018 | Volume: 15 | Issue: 4 | Pages: 199-205

10.1177/112070000501500402 | PMID 28224588 Get It

Previous methods for determining limb length during hip arthroplasty have depended on physical examination and direct measurement techniques. A radiographic technique for assessing limb length intraoperatively with a single anteroposterior (AP) pelvis radiograph was studied in 46 consecutive hip arthroplasties in 41 patients (five with bilateral arthroplasties). Of the 41 patients, 97.6% had either an average postoperative limb length discrepancy of 2.9 mm (-1 mm to +7 mm), or the limb was lengthened no more than 7 mm. This radiographic method has led to one of the most successful results reported in the literature with regard to minimizing significant limb length discrepancy or limb lengthening (maximum of 7 mm) following total hip arthroplasty. The single AP radiograph made intraoperatively with the trial implant in place is a valuable aid in determining limb length in total hip arthroplasty.
Evaluation of Non-Tissue Culture- versus Tissue Culture-Treated Microplates for Oritavancin Susceptibility Testing
Karau, Melissa J. , Patel, Robin , Yan, Qun , Patel, Robin , Yan, Qun

Mayo Clinic

Journal of Clinical Microbiology | January 24, 2018 | Volume: 56 | Issue: 4 | Pages: No page available

10.1128/jcm.02001-17 | PMID 29367298 Get It

Comparing the Measurement of Diurnal Fluctuations in Intraocular Pressure in the Same Day versus over Different Days in Glaucoma
Magacho, Leopoldo , Toscano, Daniela Araújo, Freire, Gislene, Shetty, Rajesh , Ávila, Marcos Pereira de

Mayo Clinic

European Journal of Ophthalmology | January 24, 2018 | Volume: 20 | Issue: 3 | Pages: 542-545

10.1177/112067211002000329 | PMID 20099235 Get It

Purpose. To compare the measurement of diurnal fluctuations in intraocular pressure (IOP) in the same day versus over different days in primary open-angle glaucoma. Methods. Twenty-five eyes from 25 patients with primary open-angle glaucoma were submitted to a diurnal curve on the same day, 5 measurements, 2.5 hours apart, from 8:00 AM to 6:00 PM. For the measurements on different days, we randomly selected one time point from the diurnal curve for each patient. All patients were then instructed to return every 3–7 days to complete all 5 measurements. The maximum, minimum, and IOP fluctuation were compared between the 2 methods. Results. The IOP fluctuation (maximum-minimum) was similar when we measured the IOP on different days (5.0±2.6 mmHg vs 4.0±1.2 mmHg, p=0.08). There was no difference regarding the minimum or maximum IOP assessed in the diurnal curve or over different days. There was a high correlation for the maximum IOP (r=0.863, p<0.001) and the minimum IOP (r=0.708, p<0.001) by either method of measuring during the same day or different days, as well as for all measurements (8:00 AM: r=0.718, p<0.001; 10:30 AM: r=0.479, p=0.01; 1:00 PM: r=0.628, p=0.001; 3:30 PM: r=0.757, p<0.001; and 6:00 PM: r=0.910, p<0.001). Conclusions. IOP fluctuation in primary open-angle glaucoma can be assessed using IOP measures on different days, at different time points, which strongly correlate to a diurnal curve.
Mutations causing congenital myasthenia reveal principal coupling pathway in the acetylcholine receptor ε-subunit
Shen, Xin‐Ming , Brengman, Joan M., Shen, Shelley , Durmuş, Hacer , Preethish‐Kumar, Veeramani , Yüceyar, Nur , Vengalil, Seena , Deymeer, Feza , Sine, Steven M. , Engel, Andrew G. , Nalini, Atchayaram

Mayo Clinic

JCI Insight | January 24, 2018 | Volume: 3 | Issue: 2 | Pages: No page available

10.1172/jci.insight.97826 | PMID 29367459 Get It

We identify 2 homozygous mutations in the ε-subunit of the muscle acetylcholine receptor (AChR) in 3 patients with severe congenital myasthenia: εR218W in the pre-M1 region in 2 patients and εE184K in the β8-β9 linker in 1 patient. Arg218 is conserved in all eukaryotic members of the Cys-loop receptor superfamily, while Glu184 is conserved in the α-, δ-, and ε-subunits of AChRs from all species. εR218W reduces channel gating efficiency 338-fold and AChR expression on the cell surface 5-fold, whereas εE184K reduces channel gating efficiency 11-fold but does not alter AChR cell surface expression. Determinations of the effective channel gating rate constants, combined with mutant cycle analyses, demonstrate strong energetic coupling between εR218 and εE184, and between εR218 and εE45 from the β1-β2 linker, as also observed for equivalent residues in the principal coupling pathway of the α-subunit. Thus, efficient and rapid gating of the AChR channel is achieved not only by coupling between conserved residues within the principal coupling pathway of the α-subunit, but also between corresponding residues in the ε-subunit.
Solving a Mystery . . . 8 Years Later
Jouni, Hayan, Anavekar, Nandan S., Kuzo, Ronald S.

Mayo Clinic

Journal of Investigative Medicine High Impact Case Reports | January 24, 2018 | Volume: 6 | Issue: No issue available | Pages: No page available

10.1177/2324709617752962 | PMID 29435464 Get It

Erdheim-Chester disease is a rare non-Langerhans cell histiocytosis with multisystem involvement and insidious symptoms. In this article, we describe an interesting case of Erdheim-Chester disease that was eventually diagnosed 8 years after symptoms initially started.
Clinicopathological and 123I‐FP‐CIT SPECT correlations in patients with dementia
Jung, Youngsin, Jordan, Lennon, Lowe, Val J. , Kantarci, Kejal , Parisi, Joseph E. , Murray, Melissa E. , Reichard, Ross R., Ferman, Tanis J. , Graff‐Radford, Jonathan , Savica, Rodolfo , Fields, Julie A. , Allen, Laura A., Drubach, Daniel A., Louis, Erik K. St. , Silber, Michael H. , Jack, Clifford R. , Petersen, Ronald C. , Jordan, Lennon G, St Louis, Erik K, Jack, Clifford R , St Louis, E K , Kantarci, Kejal , Murray, Melissa E , Ferman, Tanis J , Dickson, Dennis W. , Jones, David T. , Machulda, Mary M. , Knopman, David S. , Boeve, Bradley F.

Mayo Clinic

Annals of Clinical and Translational Neurology | January 24, 2018 | Volume: 5 | Issue: 3 | Pages: 376-381

10.1002/acn3.521 | PMID 29560382 Get It

AbstractThe relationship between clinicopathologic diagnosis and 123I‐FP‐CIT SPECT in 18 patients with dementia (12 with Lewy body disease) from one center in the United States was assessed. The sensitivity and specificity of abnormal 123I‐FP‐CIT SPECT with reduced striatal uptake on visual inspection for predicting Lewy body disease were 91.7% and 83.3%, respectively. The mean calculated putamen to occipital ratio (mPOR) based on regions of interest was significantly reduced in Lewy body disease compared to non‐Lewy body disease cases (P = 0.002). In this study, abnormal 123I‐FP‐CIT SPECT was strongly associated with underlying Lewy body disease pathology, supporting the utility of 123I‐FP‐CIT SPECT in the clinical diagnosis of dementia with Lewy bodies.
Modeling Neurodegenerative Microenvironment Using Cortical Organoids Derived from Human Stem Cells
Yan, Yuanwei, Song, Liqing , Bejoy, Julie , Kanekiyo, Takahisa , Bu, Guojun , Zhou, Yi , Li, Yan , Bu, Guojun , Zhao, Jing

Mayo Clinic

Tissue Engineering Part A | January 24, 2018 | Volume: 24 | Issue: 13-14 | Pages: 1125-1137

10.1089/ten.tea.2017.0423 | PMID 29361890 Get It